Manufacturer
DUOPHARMA (M) SDN. BHD.
Contents
Fluphenazine decanoate
Indication
Psychoses, Mania, Schizophrenia
Instruction
Administer via IM.
Drug interaction
Reduces antihypertensive effects of guanethidine, methyldopa and clonidine. Lithium toxicity. Reduced bioavailability with antacids. Increased risk of arrhythmia when used with drugs that prolong QT interval. May cause electrolyte disturbance when used with diuretics.Potentially Fatal: Additive CNS depressant effects with alcohol, barbiturates, hypnotics, sedatives, opiates and antihistamines.
Malaysia
